Skip To Main Content
Simon de Lusignan on Muck Rack

Simon de Lusignan

(He/Him)
Oxford
As seen in: National Institutes of Health, Nature, Wiley Online Library, PLOS Medicine, Archives of Disease in Childhood, BMJ Open, Evidence-Based Mental Health, heart, Journal of Medical Ethics (JME), MDPI and
Covers:  Clinical informatics, disease surveillance, influenza and influenza vaccination
Academic GP, doing respiratory disease surveillance, research & quality improvement using routine data + how to incorporate technology into clinical practice.

Get in touch with Simon

Contact Simon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Impact of structured medication reviews on prescribing in English primary care: a retrospective observational cohort study

|
By James Sheppard, Paul Bateman, Cynthia Wright-Drakesmith, Christopher Clark, Rebecca Barnes, Andrew Clegg, Gary A. Ford, Seema Gadhia, William Hinton, FD Richard Hobbs, Kamlesh Khunti, Gregory YH Lip, Simon de Lusignan, Sundus Jawad
| BJGP (British Journal of General Practice) Verified
Research Impact of structured medication reviews on prescribing in English primary care: a retrospective observational cohort study James P Sheppard, Paul A Bateman, Cynthia Wright-Drakesmith, Christopher Elles Clark, Rebecca K Barnes, Andrew Paul Clegg, Gary A Ford, Seema Gadhia, William Hinton, FD Richard Hobbs, Sundus Jawad, Kamlesh Khunti, Gregory YH Lip, Simon de Lusignan, Jonathan Mant, Deborah McCahon, Bernardo Meza-Torres, Rupert A Payne, Rafael Perera-Salazar, Claire Reidy, Anna...
Open in Who Shared View Duplicates (2) Issue with article?
|
By Simon de Lusignan
| Research Protocols
Open in Who Shared Issue with article?

JMIR Research Protocols - Differentiating the COVID-19 Infection and Vaccine Experiences of Patients With Systemic, Single Organ, and Overlap Immune-Mediated Inflammatory Disease: Protocol for a Secondary Analysis for Enhancing COVID-19 Vaccine Pharmacovi

|
By Simon de Lusignan
| Research Protocols
Background Study Design Overview Figure 1. The Delphi Study to Define and Risk-Stratify Immunosuppression (DESTINIES) phenotype.
Open in Who Shared Issue with article?
See all 76 licensed articles (78 Total)